Asarfi Hospital Ltd (ASARFI) is currently trading at 176.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Asarfi Hospital Limited is an integrated healthcare provider headquartered in Dhanbad, Jharkhand, operating two hospitals — a 285‑bed Super‑Specialty unit and a 65‑bed Cancer Institute (350 beds total) — offering multi‑speciality inpatient and outpatient care, diagnostics, oncology, cardiology and district‑level outreach services since 2005 and listed post a 2023 IPO. Q1 FY27 results show robust operational momentum: consolidated revenue rose ~33% YoY to about ₹47 crore, EBITDA margin near 19.9% and PAT margin at 9.0%, underpinned by improved ARPOB and higher IPD revenues; this demonstrates scalable economics in a regional market with rising demand for tertiary care. Asarfi’s oncology positioning is a material differentiator — the group operates one of only three dedicated cancer hospitals in Jharkhand and has invested in high‑end equipment (Varian TrueBeam, GE Dual‑Detector SPECT, Philips Azurion), giving Asarfi Hospital Limited a technology leadership claim that supports higher‑value case mix and referral dominance. The company is executing a clear growth playbook: geographic outreach into nearby districts, physician and nursing home onboarding, digital and hoarding campaigns, plus a strategic MoU with Gleneagles for a transplant unit and plans to migrate from BSE‑SME to the Main Board to access larger capital markets for funding expansion.

Over the past 52 weeks, Asarfi Hospital Ltd has traded between a low of ₹135.00 and a high of ₹256.95. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Asarfi Hospital Ltd has a market capitalization of approximately 347.11. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Asarfi Hospital Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 19.49 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 347.11 Cr, Asarfi Hospital Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Asarfi Hospital Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Asarfi Hospital Ltd is 19.49. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The board meeting is scheduled for Tuesday, August 25, 2026, at 11:00 AM at the company’s registered office in Dhanbad, Jharkhand.